<DOC>
	<DOCNO>NCT01120340</DOCNO>
	<brief_summary>The purpose study determine whether mesalamine effective vs. placebo prevention diverticulitis flare 24-months follow-up . The primary end-point study incidence diverticulitis flare . Will make clinical diagnosis uncomplicated diverticulitis : fever , leukocytosis , abdominal pain alter intestinal motility .</brief_summary>
	<brief_title>Evaluation Efficacy Mesalamine Long-term Prevention Diverticulitis Flares</brief_title>
	<detailed_description />
	<mesh_term>Diverticulum</mesh_term>
	<mesh_term>Mesalamine</mesh_term>
	<criteria>age â‰¥ 18 year male females patient positive history acute diverticulitis flare last year . The patient recruit complete clinical remission diverticulitis flare . patient give free inform consent complicate diverticulitis ( fistula , stenosis , abscesses and/or bleed ) ascertain hypersensitivity salicylates severe pathology interfere treatment clinical instrumental test trial clinically significant renal hepatic impairment esophageal , gastric duodenal ulcer within 30 day prior randomisation patient active malignancy type , history malignancy ( patient history malignancy surgically remove evidence recurrence least five year study enrollment also acceptable ) treatment investigational drug within previous 30 day treatment lactulose compound lower colonic pH prevent release active moiety tablet recent history suspicion alcohol abuse drug addiction patient become unable conform protocol patient ascertain pregnancy previous participation study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
</DOC>